Antitrust and Health Care: What to Expect in 2022

The big technology companies may be making headlines for antitrust scrutiny, but health care is also squarely in the crosshairs for heightened antitrust enforcement. The Federal Trade Commission (FTC) already devotes a substantial share of its resources to antitrust enforcement in health care. In 2020 alone, 46% of FTC enforcement actions were in the health care sector (2021 was similar)—and expectations are that the Biden administration will take an increasingly strict approach to health care competition issues.

In a new webinar, Manatt analyzes the latest trends in health care antitrust enforcement—and looks ahead at what to prepare for in 2022. Click here to register free and earn CLE. Key topics include:

  • Enforcement actions and private actions in health care, including the impact of 2021 actions and the expectations for 2022
  • Anticipated regulatory and enforcement activity around labor markets, “no poach” agreements, and covenants not to compete
  • Antitrust “reform” legislation—and what it means for health care
  • Continued enforcement activity in mergers, acquisitions and competitor collaborations
  • Lessons learned from the past year—and the issues to plan for in the year ahead to protect your organization

Even if you can’t make our live airing on February 3, click here to register free now, and you’ll receive a link to view the program on demand.


Stephen Libowsky, Partner, Antitrust and Litigation

Date and Time

Thursday, February 3
1:00 – 2:00 p.m. ET


Click here to register free.


CLE is pending in New York, California and Illinois.

If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at



pursuant to New York DR 2-101(f)

© 2022 Manatt, Phelps & Phillips, LLP.

All rights reserved